Drug · DIN 00000299
EES-200
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 22, 2017; first marketed December 31, 1962.
- Drug Identification Number (DIN)
- 00000299
- Company (DIN owner)
- Amdipharm LimitedNorthwood, Dublin, Ireland
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Erythromycin J01FA01
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) | 40 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 22, 2009: NOC 10433New Drug Submission (NDS) · Manufacturer name change